Paxlovid associated with decreased hospitalization rate among adults with COVID-19 - United States, April-September 2022.

Am J Transplant · 2023 · PMC9833372 · PMID 36695616

Europe PMC DOI

hedged sentence

—

closest p

—

boldest claim

The sentences

did not reach statistical significanceno p-value reported

Among persons aged 18–49 years, Paxlovid receipt was associated with lower hospitalization rates among persons who had received ≥3 mRNA vaccine doses (aHR = 0.75, 95% CI = 0.53–1.06) and those with only one underlying health condition (aHR = 0.91, 95% CI = 0.58–1.44), but these estimates did not reach statistical significance.

also in 111,027 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.